Altre lingue GL Pharm Tech Corp.

Azioni

A204840

KR7204840003

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
1.320 ^KRW	+11,39%		+11,86%	+16,20%

06/03	W Science Co., Ltd. ha completato l'acquisizione della partecipazione del 14,75% in GL Pharm Tech Corp. (KOSDAQ:A204840) da Ideal Private Equity Fund	CI
2023	GL Pharm Tech Corp. Riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund	06/03
GL Pharm Tech Corp. announced that it has received KRW 9.199999458 billion in funding from W Science Co., Ltd.	06/03
GL Pharm Tech to Raise 9.2 Billion Won via Share Issuance; Shares Decline 7%	15/09/23
GL Pharm Tech Corp. announced that it expects to receive KRW 9.199999458 billion in funding from W Science Co., Ltd.	14/09/23
W Science Co., Ltd. agreed to acquire a 14.7% stake in GL Pharm Tech Corp.	14/09/23
GL Pharm Tech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt	17/03/23
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt	17/03/22
GL Pharm Tech Corp. announced that it expects to receive KRW 8.999999634 billion in funding from Ideal Private Equity Fund	23/11/20
GL Pharm Tech Corp. announced that it has received KRW 1.000000232 billion in funding from Kyperion Co., Ltd.	29/09/20
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000232 billion in funding from Kyperion Co., Ltd.	21/09/20
GL Pharm Tech Corp. announced that it has received KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.	12/08/20
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.	29/07/20
GL Pharm Tech Corp. announced that it has received KRW 3.1 billion in funding from Unione Communications Co., Ltd.	13/05/20
GL Pharm Tech Corp. announced that it expects to receive KRW 3.1 billion in funding from Unione Communications Co., Ltd. and other investors	07/05/20
Crown Pharm Co., Ltd. announced that it has received KRW 1.00001 billion in funding from GL Pharm Tech Corp.	17/12/18
Crown Pharm Co., Ltd. announced that it has received KRW 3.00003 billion in funding from GL Pharm Tech Corp.	23/05/18
GL Pharm Tech Corp. announced that it has received KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC. and other investors	14/05/18
GL Pharm Tech Corp. announced that it expects to receive KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC., and other investors	11/05/18
GL Pharm Tech Corp. completed the acquisition of remaining 67.91% stake in Crown Pharm Co., Ltd.	26/01/18

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue GL Pharm Tech Corp.

Azioni

A204840

KR7204840003

Altre lingue

Filtri